Titan Biotech Ltd — Board Meeting, 26-05-2025: Board Meeting

Titan Biotech Limited has announced a board meeting to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025. The board will also discuss a potential dividend on equity shares for the year. The company’s trading window for designated persons has been closed since April 1, 2025, and will remain shut until 48 hours after the financial results are declared. This highlights key upcoming financial updates critical for shareholders.